What does a day 21 progesterone level indicate about ovulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Day 21 Progesterone Level as an Indicator of Ovulation

A day 21 progesterone level is a reliable hormonal indicator of ovulation, with levels ≥5 ng/ml (≥16 nmol/L) confirming that ovulation has occurred in that menstrual cycle. 1, 2

Understanding Ovulation Timing and Progesterone

  • During an average 28-day menstrual cycle, ovulation generally occurs during days 9-20 3
  • After ovulation occurs, the empty follicle transforms into the corpus luteum, which produces progesterone 1
  • Progesterone levels rise significantly after ovulation during the luteal phase of the menstrual cycle 2
  • Day 21 testing is based on the assumption of a 28-day cycle with ovulation occurring around day 14, making day 21 the approximate mid-luteal phase 1

Interpreting Day 21 Progesterone Results

  • A serum progesterone level ≥5 ng/ml (≥16 nmol/L) on day 21 confirms ovulation with high specificity (98.4%) and good sensitivity (89.6%) 2
  • Progesterone levels <5 ng/ml may indicate:
    • Anovulation (no ovulation occurred) 1, 4
    • Mistimed sample (tested too early or too late relative to actual ovulation) 1
    • Luteal phase defect (ovulation occurred but with inadequate corpus luteum function) 4

Clinical Applications

  • Day 21 progesterone testing is valuable for:
    • Evaluating infertility by confirming ovulation 4, 5
    • Assessing menstrual irregularities 1
    • Diagnosing conditions like polycystic ovary syndrome (PCOS) that may cause anovulation 1
    • Monitoring response to ovulation induction treatments 5

Important Considerations and Pitfalls

  • The "day 21" timing is based on a 28-day cycle; for women with irregular cycles, testing should be performed approximately 7 days before expected menses (mid-luteal phase) 1
  • A single low progesterone value should not be considered definitive proof of anovulation without considering cycle timing 6
  • Some women with normal ovulation may occasionally have cycles with progesterone levels <5 ng/ml 6, 4
  • Medications, particularly hormonal contraceptives, can suppress normal hormone patterns and affect progesterone levels 1
  • Serial testing over multiple cycles provides more reliable information than a single measurement 4

Alternative and Complementary Assessment Methods

  • Basal body temperature charting (temperature rises after ovulation due to progesterone) 5
  • Cervical mucus changes (becomes clear and stretchy near ovulation) 5
  • Urinary LH testing (surge precedes ovulation by 24-36 hours) 1
  • Transvaginal ultrasound (can directly visualize follicular development and collapse) 4

By combining day 21 progesterone measurement with clinical history and other ovulation indicators, clinicians can accurately assess ovulatory function and guide appropriate management for patients with fertility concerns or menstrual disorders.

References

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inadequate luteal phase usually indicates ovulatory dysfunction: observations from serial hormone and ultrasound monitoring of 115 cycles.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1987

Research

Plasma progesterone levels as an index of ovulation.

British journal of obstetrics and gynaecology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.